Avantax Planning Partners, Inc. Mannkind Corp Transaction History

Avantax Planning Partners, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 06, 2021	SELL	$3.14 - $6.14 $36,832 - $72,022	-11,730 Closed	0 $0
Q3 2020 Oct 28, 2020	BUY	$1.56 - $2.08 $249 - $332	160 Added 1.38%	11,730 $22,000
Q2 2020 Jul 15, 2020	SELL	$0.94 - $2.21 $564 - $1,326	-600 Reduced 4.93%	11,570 $20,000
Q4 2018 Feb 14, 2019	SELL	$1.02 - $2.05 $168 - $338	-165 Reduced 1.34%	12,170 $13,000
Q3 2017 Oct 19, 2017	BUY	$1.15 - $2.29 $14,185 - $28,247	12,335	12,335 $27,000

244

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.65B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Avantax Planning Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Avantax Planning Partners, Inc. with notifications on news.